Understanding how STAT3 affects NK cell function in different contexts
Investigating the molecular basis of context-dependent STAT3 function in NK cells
This study is looking at how a protein called STAT3 helps natural killer (NK) cells, which are important for fighting off viruses, and it aims to understand how different signals affect this protein's role, so we can learn more about how our immune system works and how it might help in treating cancer and viral infections.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10985381 on NIH RePORTER |
What this research studies
This research investigates the role of the STAT3 protein in Natural Killer (NK) cells, which are essential for fighting viral infections. The study aims to determine how various signals influence STAT3's function, particularly in different infection scenarios. By examining how STAT3 affects NK cell growth and activity, the research seeks to uncover important mechanisms that could enhance our understanding of immune responses and cancer biology. Patients may benefit from insights gained about NK cell function in viral infections and cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with viral infections or cancers where NK cell function is critical.
Not a fit: Patients with conditions unrelated to NK cell function or those not experiencing viral infections or cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for enhancing immune responses against viral infections and cancer.
How similar studies have performed: Previous research has shown that understanding the molecular mechanisms of immune cells can lead to significant advancements in treatment strategies, suggesting this approach has potential for success.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Grassmann, Simon — Sloan-Kettering Inst Can Research
- Study coordinator: Grassmann, Simon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.